Baxter International Inc. (NYSE:BAX)

Baxter International Inc. (Baxter) is a global, diversified healthcare company. The Company through its subsidiaries, develops, manufactures and markets products that sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operates in two segments: BioScience and Medical Products. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes. The Company also offers early-stage pipeline of protein therapeutics for autoimmune and allergic diseases.

Official website: www.baxter.com